NEURACEQ DIN 02461927
Health Canada record
| Active ingredient(s) | FLORBETABEN (18F) 5000 MBq |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09AX06 FLORBETABEN 18F |
| Original market date | 01-Jul-2017 |
| Current status date | 13-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Isologic Innovative Radiopharmaceuticals of Ontario Limited — licence 102120, currently licensed, last inspection rating I (2026-08-25).
No Canadian shortage report is currently matched to this DIN.
Request a quote for NEURACEQ